Category: Oncology/Hematology
Oncology/Hematology market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Embolization in Interventional Oncology
The 2025-2030 World Outlook for Embolization in Interventional Oncology This study covers the world outlook for embolization in interventional oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Kidney Cancer-Treating Drugs
The 2025-2030 World Outlook for Kidney Cancer-Treating Drugs This study covers the world outlook for kidney cancer-treating drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Veterinary Oncology
The 2025-2030 World Outlook for Veterinary Oncology This study covers the world outlook for veterinary oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Blockbuster Oncology Brands
The 2025-2030 World Outlook for Blockbuster Oncology Brands This study covers the world outlook for blockbuster oncology brands across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Transitional Cell Bladder Cancer Therapeutics
The 2025-2030 World Outlook for Transitional Cell Bladder Cancer Therapeutics This study covers the world outlook for transitional cell bladder cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Clinical Oncology Next Generation Sequencing
The 2025-2030 World Outlook for Clinical Oncology Next Generation Sequencing This study covers the world outlook for clinical oncology next generation sequencing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More
-
The 2025-2030 World Outlook for Targeted Therapy Kidney Cancer Drugs
The 2025-2030 World Outlook for Targeted Therapy Kidney Cancer Drugs This study covers the world outlook for targeted therapy kidney cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Oncology Based Molecular Diagnostics
The 2025-2030 World Outlook for Oncology Based Molecular Diagnostics This study covers the world outlook for oncology based molecular diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics
The 2025-2030 World Outlook for Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics This study covers the world outlook for acute lymphocytic-lymphoblastic leukemia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ... Read More
-
The 2025-2030 World Outlook for Lung Cancer Diagnostics
The 2025-2030 World Outlook for Lung Cancer Diagnostics This study covers the world outlook for lung cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Immuno-Oncology Immune Checkpoint Inhibitors
The 2025-2030 World Outlook for Immuno-Oncology Immune Checkpoint Inhibitors This study covers the world outlook for immuno-oncology immune checkpoint inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More
-
The 2025-2030 World Outlook for Non-Hematological Cancers
The 2025-2030 World Outlook for Non-Hematological Cancers This study covers the world outlook for non-hematological cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments
The 2025-2030 World Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments This study covers the world outlook for non-Hodgkin's lymphoma and chronic lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics This study covers the world outlook for non-Hodgkin lymphoma chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I ... Read More
-
The 2025-2030 World Outlook for Oncolytic Virotherapy Cancer Gene Therapies
The 2025-2030 World Outlook for Oncolytic Virotherapy Cancer Gene Therapies This study covers the world outlook for oncolytic virotherapy cancer gene therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Lymphoma Therapeutics
The 2025-2030 World Outlook for Lymphoma Therapeutics This study covers the world outlook for lymphoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Gynaecological Cancer Drugs
The 2025-2030 World Outlook for Gynaecological Cancer Drugs This study covers the world outlook for gynaecological cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Cancer Biologics
The 2025-2030 World Outlook for Cancer Biologics This study covers the world outlook for cancer biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Chemotherapy Therapeutics
The 2025-2030 World Outlook for Colorectal Cancer Chemotherapy Therapeutics This study covers the world outlook for colorectal cancer chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Immunoassays for Cancer and Tumor Profiling
The 2025-2030 World Outlook for Immunoassays for Cancer and Tumor Profiling This study covers the world outlook for immunoassays for cancer and tumor profiling across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Chronic Myelogenous Leukemia Treatments
The 2025-2030 World Outlook for Chronic Myelogenous Leukemia Treatments This study covers the world outlook for chronic myelogenous leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Lung Cancer Surgeries
The 2025-2030 World Outlook for Lung Cancer Surgeries This study covers the world outlook for lung cancer surgeries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Lung Cancer Therapeutics
The 2025-2030 World Outlook for Lung Cancer Therapeutics This study covers the world outlook for lung cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Basal Cell Carcinoma Surgeries
The 2025-2030 World Outlook for Basal Cell Carcinoma Surgeries This study covers the world outlook for basal cell carcinoma surgeries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Therapeutics
The 2025-2030 World Outlook for Ovarian Cancer Therapeutics This study covers the world outlook for ovarian cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
Research Assistance
